Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn which credit cards offer no annual fee along with bonus rewards. Make an informed choice for your finances!
28,655 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A federally funded health study tied to the Biden administration finds no safe level of alcohol and warns risks rise ...
BNB rose toward the $660 mark as traders push bets higher in an aggressive spot market. Open interest on BNB futures ...
SpaceX used its soaring stock to fund a $60 billion Cursor acquisition in stock, turning a fresh IPO into a powerful ...
Finance of America reported a profitable first quarter, reversing Q4 losses as originations climbed and portfolio gai...
Oil prices drop to a three-month low following news of a Trump Iran framework, signaling potential relief for inflati...
Ethereum sits in a tight range while on-chain tokenized Treasuries on the network surpass $8 billion, marking a major...
Algorand has announced a detailed roadmap to achieve full post-quantum cryptography by the end of 2027, marking a maj...
XRP holds firm while BTC and ETH slide, buoyed by steady ETF flows into XRP products and a surge in XRP wallet activi...
A Korea-led chip selloff pulled AMD and Intel lower while Nvidia slipped, prompting analysts to frame the move as hea...
Oil prices decline as investors weigh possible progress toward a Middle East peace agreement. Markets respond to dipl...
A data-driven model now sees roughly 36% upside for Qualcomm stock within a year, even after a choppy period around i...